Interviews with Key Healthcare Opinion Leaders - Episode #74

By Tamara Thomas - Last Updated: April 5, 2024

Andrew Hertler, MD, talks about the importance of prophylactic mastectomy for individuals carrying high-risk BRCA1, BRCA2, and other deleterious gene mutations.

Advertisement

Related Podcasts

Interviews with Key Healthcare Opinion Leaders - Episode #86
Interviews with Key Healthcare Opinion Leaders - Episode #85
Interviews with Key Healthcare Opinion Leaders - Episode #84
Interviews with Key Healthcare Opinion Leaders - Episode #83
Interviews with Key Healthcare Opinion Leaders – Episode #82
Advertisement
Advertisement
Latest News

Black Men Face Slow PSA Screening Recovery Rate Following the COVID-19 Pandemic

December 2, 2024

Pediatric RISE: Direct Cash Support Pilot Improves Quality of Life for Families Facing Pediatric Cancer

December 2, 2024

While Some IUDs Are Associated with Increased Breast Cancer Risk, The Risk Remains Low

December 2, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • Who We Are

    About Us

    Editorial Policy

    Contributors & Partners

    Connect

    eNewsletters

    Contact Us

    Work With Us

    Advertising

    Our Network

    GU Oncology Now

    Blood Cancers Today

    Cancer Nursing Today

    DocWire News

    MashupMD

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy